Tax Rate: 28.33%
Is the tax rate high or low?
The tax rate of 28.33% is 191% above its 5-year average of 9.72%, near the high end of its 5-year range (-105.88%–40.98%).
1.38% below its 12-month average of 28.73%.
TECH Tax Rate
Reported quarterly effective tax rate; periods with non-meaningful pretax income are omitted.
TECH Average Tax Rate Chart
TECH Current vs Average Tax Rate Chart
TECH Tax Rate Metrics
TAX RATE
28.33%
TAX RATE AVG TTM
28.73%
TAX RATE AVG 3Y
19.26%
TAX RATE AVG 5Y
14.41%
TAX RATE AVG 10Y
18.54%
TAX RATE AVG 15Y
22.76%
TAX RATE AVG 20Y
25.99%
CURRENT VS TTM AVG
-1.38%
CURRENT VS 3Y AVG
+47.13%
CURRENT VS 5Y AVG
+96.65%
CURRENT VS 10Y AVG
+52.83%
CURRENT VS 15Y AVG
+24.47%
CURRENT VS 20Y AVG
+9.02%
Tax Rate Formula & Definition
Tax rate measures income tax expense as a percentage of income before tax. It helps compare tax efficiency and identify unusual tax effects.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Tax Rate FAQ
- What is the tax rate for Bio-Techne Corporation (TECH)?
- The tax rate for TECH stock is 28.33%.
- Is Bio-Techne Corporation's tax rate high or low?
- The tax rate of 28.33% is 191% above its 5-year average of 9.72%, near the high end of its 5-year range (-105.88%–40.98%).
- What is the TTM average tax rate for Bio-Techne Corporation (TECH)?
- The TTM average tax rate for TECH stock is 28.73%.
- What is the 3Y average tax rate for Bio-Techne Corporation (TECH)?
- The 3Y average tax rate for TECH stock is 19.26%.
- What is the 5Y average tax rate for Bio-Techne Corporation (TECH)?
- The 5Y average tax rate for TECH stock is 14.41%.
- What is the 10Y average tax rate for Bio-Techne Corporation (TECH)?
- The 10Y average tax rate for TECH stock is 18.54%.
- What is the 15Y average tax rate for Bio-Techne Corporation (TECH)?
- The 15Y average tax rate for TECH stock is 22.76%.
- What is the 20Y average tax rate for Bio-Techne Corporation (TECH)?
- The 20Y average tax rate for TECH stock is 25.99%.
TECH Tax Rate History
| DATE | TAX RATE |
|---|---|
| 2026-03-31 | 28.33% |
| 2025-12-31 | 25.16% |
| 2025-09-30 | 20.43% |
| 2025-03-31 | 40.98% |
| 2024-12-31 | 18.63% |
| 2024-09-30 | 16.36% |
| 2024-06-30 | 2.58% |
| 2024-03-31 | 19.69% |
| 2023-12-31 | 17.74% |
| 2023-09-30 | -2.90% |
| 2023-06-30 | 14.53% |
| 2023-03-31 | 12.44% |
| 2022-12-31 | 24.72% |
| 2022-09-30 | 13.48% |
| 2022-06-30 | 21.68% |
| 2022-03-31 | 12.55% |
| 2021-12-31 | 16.38% |
| 2021-09-30 | -2.37% |
| 2021-06-30 | -105.88% |
| 2021-03-31 | -0.11% |
| 2020-12-31 | 18.14% |
| 2020-09-30 | 15.11% |
| 2020-06-30 | 4.36% |
| 2020-03-31 | 22.19% |
| 2019-12-31 | 20.42% |
| 2019-09-30 | 19.14% |
| 2019-06-30 | 27.76% |
| 2019-03-31 | 10.47% |
| 2018-12-31 | 19.35% |
| 2018-09-30 | 1.04% |
| 2018-06-30 | 27.31% |
| 2018-03-31 | 20.99% |
| 2017-12-31 | -124.78% |
| 2017-09-30 | 30.93% |
| 2017-06-30 | 26.22% |
| 2017-03-31 | 28.77% |
| 2016-12-31 | 53.37% |
| 2016-09-30 | 32.51% |
| 2016-06-30 | 32.15% |
| 2016-03-31 | 28.71% |
| 2015-12-31 | 26.92% |
| 2015-09-30 | 28.70% |
| 2015-06-30 | 31.15% |
| 2015-03-31 | 37.33% |
| 2014-12-31 | 21.98% |
| 2014-09-30 | 30.90% |
| 2014-06-30 | 32.01% |
| 2014-03-31 | 31.32% |
| 2013-12-31 | 30.82% |
| 2013-09-30 | 30.83% |
| 2013-06-30 | 30.30% |
| 2013-03-31 | 25.52% |
| 2012-12-31 | 32.27% |
| 2012-09-30 | 32.43% |
| 2012-06-30 | 32.93% |
| 2012-03-31 | 26.50% |
| 2011-12-31 | 31.84% |
| 2011-09-30 | 32.05% |
| 2011-06-30 | 34.07% |
| 2011-03-31 | 31.55% |
| 2010-12-31 | 29.57% |
| 2010-09-30 | 32.30% |
| 2010-06-30 | 32.92% |
| 2010-03-31 | 21.84% |
| 2009-12-31 | 32.64% |
| 2009-09-30 | 32.58% |
| 2009-06-30 | 32.17% |
| 2009-03-31 | 32.32% |
| 2008-12-31 | 30.83% |
| 2008-09-30 | 33.42% |
| 2008-06-30 | 32.71% |
| 2008-03-31 | 31.17% |
| 2007-12-31 | 33.56% |
| 2007-09-30 | 33.61% |
| 2007-06-30 | 32.86% |
| 2007-03-31 | 35.16% |
| 2006-12-31 | 33.89% |
| 2006-09-30 | 33.93% |
| 2006-06-30 | 34.19% |
| 2006-03-31 | 34.71% |
| 2005-12-31 | 33.68% |
| 2005-09-30 | 33.30% |
| 2005-06-30 | 32.61% |
| 2005-03-31 | 33.92% |
| 2004-12-31 | 34.17% |
| 2004-09-30 | 34.74% |
| 2004-06-30 | 37.04% |
| 2004-03-31 | 36.24% |
| 2003-12-31 | 34.98% |
| 2003-09-30 | 35.05% |
| 2003-06-30 | 35.13% |
| 2003-03-31 | 35.17% |
| 2002-12-31 | 34.07% |
| 2002-09-30 | 34.34% |
Related Metrics
About Bio-Techne Corporation
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Kim Kelderman